Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy

ObjectivesInduction chemotherapy (ICT) followed by definitive treatment is an accepted non-surgical approach for locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, ICT remains a challenge for cisplatin-unfit patients. We evaluated paclitaxel and cetuximab (P-C) as ICT...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Frontiers in Oncology
Päätekijät: Juan A. Marín-Jiménez, Marc Oliva, Paloma Peinado Martín, Santiago Cabezas-Camarero, Maria Plana Serrahima, Gonzalo Vázquez Masedo, Alicia Lozano Borbalas, María N. Cabrera Martín, Anna Esteve, María C. Iglesias Moreno, Esther Vilajosana Altamis, Lorena Arribas Hortigüela, Miren Taberna Sanz, Pedro Pérez-Segura, Ricard Mesía
Aineistotyyppi: Artikkeli
Julkaistu: Frontiers Media S.A. 2022-07-01
Aiheet:
Head and neck squamous cell carcinoma
Head and neck cancer
Induction chemotherapy
Paclitaxel
Cetuximab
Radiotherapy
Linkit:https://www.frontiersin.org/articles/10.3389/fonc.2022.953020/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.953020/full

Samankaltaisia teoksia